Cited by — Immunogenic cell death as a mechanism of synergy between sunitinib and 177Lu-DOTATATE peptide receptor radionuclide therapy in pancreatic neuroendocrine tumors | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Immunogenic cell death as a mechanism of synergy between sunitinib and 177Lu-DOTATATE peptide receptor radionuclide therapy in pancreatic neuroendocrine tumors.
No admitted local citation edges point to this work yet.
